Related Experiment Video
Updated: May 10, 2025

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
Synergizing Catalysis with Post-catalysis Pseudo-Iron Release by Building Dynamic Catalytic Active Sites in Diatomic
Songjing Zhong1,2, Zeyu Zhang1, Zhuo Wang1
1Beijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing 101400, P. R. China.
Abstract:
Biomimetic nanozymes hold considerable promise for cancer therapy, but their therapeutic potential is often constrained by their limited catalytic activity. Here, we present a Ga/Zn diatomic nanozyme (Ga/Zn-NC) with a well-defined geometric structure and electronic configuration designed to emulate peroxidase and glutathione oxidase with exceptional catalytic activities, enabling cascade catalysis. We demonstrate that the formation of Ga-Zn metal bonding is essential for accelerating electron transfer and reducing the reaction energy barrier, thus enhancing the catalytic performance. Within the tumor microenvironment, the catalytic actions of Ga/Zn-NC induce oxidative damage and sensitize breast cancer cells to ferroptosis. Concurrently, the release of gallium from Ga/Zn-NC with "pseudo-iron" activity disrupts iron metabolism and activates a self-amplifying ferroptosis pathway, synergizing with the enzyme's catalytic activity to potentiate ferroptosis and apoptosis, thereby achieving remarkable efficacy against tumors.
More Related Videos
08:40Synthesis of Metal Nanoparticles Supported on Carbon Nanotube with Doped Co and N Atoms and its Catalytic Applications in Hydrogen Production
Published on: December 6, 2021
05:36Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
Published on: February 23, 2024
Related Concept Videos
Introduction to Mechanisms of Enzyme Catalysis
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Catalysis
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...